The recent merger between Allergan PLC (NYSE:AGN) and Pfizer is still the talk of the town despite fears that U.S.
Depomed Inc (NASDAQ:DEPO) issued the following statement regarding Horizon Pharma PLC (NASDAQ:HZNP) decision to withdraw its acquisition proposal. The withdrawal follows a ruling today …
The biotechnology sector remains busy at the midpoint of the fourth quarter. This week, analysts remain bullish on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) due to …
Depomed Inc (NASDAQ:DEPO) announced that it has entered into a definitive agreement to acquire the U.S.
Depomed Inc (NASDAQ:DEPO) issued the following statement in response to numerous recent reports surrounding Horizon Pharma plc’s (NASDAQ:HZNP) business model, in particular concerns raised …
Depomed Inc (NASDAQ:DEPO) announced that its Board of Directors, after careful consideration and in consultation with its financial and legal advisors, has unanimously …
While an estimated 36 million Americans suffer from migraine[2], only one of every three people speak to a doctor[3] about their headaches. Of …
Depomed, Inc. (NASDAQ:DEPO) confirmed that Horizon Pharma PLC (NASDAQ:HZNP) has announced that it has commenced an unsolicited exchange offer to acquire all of the …
Depomed Inc (NASDAQ:DEPO) announced that its Board of Directors, after careful consideration and with the assistance of its financial and legal advisors, has unanimously …
By Terry Chrisomalis Oncolytics Biotech, Inc. (USA) On July 6, 2015 shares of Oncolytics Biotech, Inc.